These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy. Porter JD; Merriam AP; Leahy P; Gong B; Feuerman J; Cheng G; Khanna S Hum Mol Genet; 2004 Feb; 13(3):257-69. PubMed ID: 14681298 [TBL] [Abstract][Full Text] [Related]
6. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy. Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404 [TBL] [Abstract][Full Text] [Related]
7. Identification of quantitative polymerase chain reaction reference genes suitable for normalising gene expression in the brain of normal and dystrophic mice and dogs. Crawford AH; Hildyard JCW; Wells DJ; Piercy RJ Wellcome Open Res; 2021; 6():84. PubMed ID: 37942409 [No Abstract] [Full Text] [Related]
8. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20. Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823 [TBL] [Abstract][Full Text] [Related]
9. Electrotransfer of the full-length dog dystrophin into mouse and dystrophic dog muscles. Pichavant C; Chapdelaine P; Cerri DG; Bizario JC; Tremblay JP Hum Gene Ther; 2010 Nov; 21(11):1591-601. PubMed ID: 20553115 [TBL] [Abstract][Full Text] [Related]
10. Lentiviral Micro-dystrophin Gene Treatment into Late-stage mdx Mice for Duchenne Muscular Dystrophy Disease. Eren SA; Tastan C; Karadeniz KB; Turan RD; Cakirsoy D; Kancagi DD; Yilmaz SU; Oztatlici M; Oztatlici H; Ozer S; Tumentemur G; Baykal AT; Ovali E Curr Gene Ther; 2023; 23(4):304-315. PubMed ID: 37032509 [TBL] [Abstract][Full Text] [Related]
11. Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice. Porter JD; Merriam AP; Leahy P; Gong B; Khanna S Hum Mol Genet; 2003 Aug; 12(15):1813-21. PubMed ID: 12874102 [TBL] [Abstract][Full Text] [Related]
12. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways. Sadler KJ; Gatta PAD; Naim T; Wallace MA; Lee A; Zaw T; Lindsay A; Chung RS; Bello L; Pegoraro E; Lamon S; Lynch GS; Russell AP Exp Physiol; 2021 Jul; 106(7):1597-1611. PubMed ID: 33963617 [TBL] [Abstract][Full Text] [Related]
13. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle. Yuasa K; Nakamura A; Hijikata T; Takeda S BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116 [TBL] [Abstract][Full Text] [Related]
14. Altered bone-regulating myokine expression in skeletal muscle Of Duchenne muscular dystrophy mouse models. Zhou S; Qian B; Wang L; Zhang C; Hogan MV; Li H Muscle Nerve; 2018 Oct; 58(4):573-582. PubMed ID: 30028902 [TBL] [Abstract][Full Text] [Related]
15. Increased collagen cross-linking is a signature of dystrophin-deficient muscle. Smith LR; Hammers DW; Sweeney HL; Barton ER Muscle Nerve; 2016 Jun; 54(1):71-8. PubMed ID: 26616495 [TBL] [Abstract][Full Text] [Related]
17. A web-accessible complete transcriptome of normal human and DMD muscle. Bakay M; Zhao P; Chen J; Hoffman EP Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S125-41. PubMed ID: 12206807 [TBL] [Abstract][Full Text] [Related]
18. Exercise increases utrophin protein expression in the mdx mouse model of Duchenne muscular dystrophy. Gordon BS; Lowe DA; Kostek MC Muscle Nerve; 2014 Jun; 49(6):915-8. PubMed ID: 24375286 [TBL] [Abstract][Full Text] [Related]
19. Localized expression of specific P2X receptors in dystrophin-deficient DMD and mdx muscle. Jiang T; Yeung D; Lien CF; Górecki DC Neuromuscul Disord; 2005 Mar; 15(3):225-36. PubMed ID: 15725584 [TBL] [Abstract][Full Text] [Related]
20. Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy. Wuebbles RD; Sarathy A; Kornegay JN; Burkin DJ Dis Model Mech; 2013 Sep; 6(5):1175-84. PubMed ID: 23846963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]